Fundraising Fox

Rachel Humphrey

Founder

Founding Chief Executive Officer at Normunity

Boston, Massachusetts, United States

FoundedNormunity

Founding Chief Executive Officer at Normunity

Intro paths

→

In turn, Rachel can intro founders to Normunity's investors below.

Normunity's investors · 10

Canaan PartnersStamford · $500K – $20M checks · since 2025Connecticut InnovationsNew Haven · $500K – $2M checks · since 2025HongShan Capital GroupHong Kong · $100K – $50M checks · since 2025Osage Venture PartnersBala Cynwyd · $500K – $3M checks · since 2025Pfizer Venture Investments$5M – $20M checksPfizer Venturessince 2025Samsara BioCapitalPalo Alto · since 2025Sanofi VenturesCambridge · $5M checks · since 2025Taiho Ventures, LLCMenlo Park · since 2025YK BioventuresBurlingame · since 2025

Co-founders at Normunity

LC
Lieping ChenScientific Founder

Experience

  1. Affibody ABIndependent Board Membercurrent2025 — presentStockholm, Stockholm County, Sweden
  2. Voro TherapeuticsChair of the Board of Directorscurrent2025 — present
  3. NormunityPresident and Founding CEOcurrent2021 — presentUnited States
  4. Pyxis OncologyIndependent Board Directorcurrent2022 — present
  5. Sporos BioventuresIndependent Board Directorcurrent2021 — present
  6. Grey Wolf TherapeuticsScientific Advisory Board Membercurrent2021 — presentGreater London, England, United Kingdom
  7. HotSpot Therapeutics, Inc.Scientific Advisory Board Membercurrent2021 — presentBoston, Massachusetts, United States
  8. Xilio Therapeutics, Inc.Independent Board Director2019 — 2022Cambridge, Massachusetts, United States
  9. Black Diamond TherapeuticsChief Medical Officer2020 — 2021Cambridge, Massachusetts, United States
  10. Treadwell Therapeutics, Inc.Board Director and Chief Medical Officer2020New York, New York
  11. TIO BioventuresHead Of Research And Development2020New York, New York
  12. CytomX TherapeuticsSVP, Chief Medical Officer2015 — 2019South San Francisco, CA
  13. CytomX TherapeuticsMember Board of Directors2015
  14. Eli Lilly and CompanyVice President, Head of Immuno-Oncology2015
  15. AstraZenecaSVP, Head of Immuno-Oncology2013 — 2014Gaithersburg, Maryland
  16. Mirati Therapeutics IncChief Medical Officer2012 — 2013San Diego, California and Princeton, NJ
  17. Bristol-Myers SquibbVice President, Development Lead, Immuno-oncology2004 — 2012Princeton, NJ
  18. Bristol-Myers SquibbExecutive Director, Global Research and Development2003 — 2004Wallingford, CT
  19. Bayer PharmaceuticalsDirector, Global Clinical Leader, R & D1997 — 2003West Haven, CT

Skills & more

Clinical DevelopmentOncologyPharmaceutical IndustryDrug Development78Clinical TrialsTranslational Medicine8Biomarkers34BiotechnologyMedical Affairs44Lifesciences9Drug Discovery31Immunology27
+8 moreClinical ResearchCancerTherapeutic AreasInfectious DiseasesCellCommercializationINDBiopharmaceuticals

Languages Hebrew

From Rachel's professional profile.

Frequently asked questions

Who is Rachel Humphrey?
Founding Chief Executive Officer at Normunity
Where does Rachel Humphrey work?
Rachel Humphrey is Founding Chief Executive Officer of Normunity.
What companies did Rachel Humphrey found?
Rachel Humphrey founded Normunity.
Where did Rachel Humphrey go to school?
Rachel Humphrey studied at The Johns Hopkins University School of Medicine (Residency, Internal Medicine); Case Western Reserve University School of Medicine (MD); Harvard University (BA, Biochemistry).

Are you in our directory? — or find your own page and tap it there to see your paths to every investor.

Founder mafias

The Johns Hopkins University School of Medicine mafia27

Also came through, then founded or led a company.

Derek JantzDoctor of Philosophy - PhDFounded Precision BioSciences +1Wendye RobbinsFellowshipFounded Limerick Biopharma +1Hugh Y. Rienhoff, Jr., M.D.MDFounded FerroKin Biosciences +1Lawrence HofmannResidencyFounded Grand Rounds +1Victor VelculescuDoctor of Medicine and Philosophy- MD/PhDFounded Personal Genome Diagnostics +1Greg HornerMDFounded PulzAid

+ 20 more

Case Western Reserve University School of Medicine mafia9

Also came through, then founded or led a company.

Madan KandulaInternship, SurgeryFounded Adventknows +1Kingsley R. ChinFELLOW IN SPINE SURGERYFounded IndependentmedexpertCurtis DobrowolskiDoctor of Philosophy (PhD)Founded Nava TherapeuticsRadu IancuPhDFounded KeborMedElizabeth ClayborneMA BioethicsFounded NasaClipKarl Y. HostetlerM.D.Founded Antiva Biosciences

+ 2 more

Xilio Therapeutics mafia3

Also came through, then founded or led a company.

Nessan BerminghamExec ChairFounded Korro Bio +2Tim ClacksonPresident and CTOFounded Theseus Pharmaceuticals

CytomX mafia2

Also came through, then founded or led a company.

Krishna PoluChief Medical OfficerFounded Commit Biologics

Grey Wolf Therapeutics mafia2

Also came through, then founded or led a company.

Peter JoyceCo-founderFounded Pathios Therapeutics

Same school

Also attended The Johns Hopkins University School of Medicine59

Hal PazInvestor at Khosla VenturesRochelle WalenskyExecutive Partner at Flare Capital PartnersBeth SeidenbergFounding Managing Director at Westlake Village BioPartnersStephen P. ZacharyManaging Partner at Sands Capital VenturesS.K. LeeExecutive Coach at Roble VenturesEric HsuAnalyst, Private Equity at Sofinnova Ventures

+ 53 more

Also attended Case Western Reserve University School of Medicine14

Richard RansohoffVenture Partner at Third Rock VenturesTodd PonskyChief Innovation Officer at Flare Capital PartnersTarek El-SawyVenture Partner at RaivenGlenn PierceScientific Advisory Group Co-Chair at Pathway to CuresKingsley R. ChinManaging Partner at KIC VenturesSteven SchachterAdvisor, Medtech at Iaso Ventures

+ 8 more

Also attended Harvard University2,000

Ron ConwayFounder of SV AngelAlfred LinPartner at Sequoia CapitalChris DixonFounder & Managing Partner of a16z crypto at Andreessen HorowitzSarah TavelVenture Partner at BenchmarkDanny RimerPartner at Index VenturesLaela SturdyManaging Partner at CapitalG

+ 1,994 more

Shared employers

Also worked at Voro Therapeutics3

Sophia LaiVenture Associate at 82VSUgur EskiocakFounder / EIR at 82VSTatiana NovobrantsevaChief Scientific Officer at NextPoint Therapeutics

Also worked at Xilio Therapeutics, Inc.7

Dan LynchInvestor at GV (Google Ventures)Nessan BerminghamInvestor at Khosla VenturesAlex Badamchi-ZadehVice President at SV Health InvestorsKeno GutierrezGeneral Partner at BioGeneration VenturesPeter DudekPresident at MRL Ventures FundUgur EskiocakFounder / EIR at 82VS

+ 1 more

Also worked at CytomX Therapeutics3

Bryan A. IrvingSenior Advisor at Frazier Life SciencesCharles (Charlie) FuchsSenior Advisor at Frazier Life SciencesKrishna PoluPrincipal at Red Tree Venture

Also worked at Eli Lilly and Company117

David MollerInvestor at Third Rock VenturesJesper GromadaInvestor at Third Rock VenturesMark LevinRetired Founding Partner at Third Rock VenturesNatalie FurneyGlobal General Counsel at Takeda VenturesRhonda PachecoPresident, U.S. Business Unit and U.S. Country Head at Takeda VenturesCarlos PayaVenture Partner at Ysios Capital

+ 111 more